发布求助
文献互助 智能选刊 最新文献

Immuno-oncology insights最新文献

筛选
英文 中文
Putting the patient first 以病人为先
Immuno-oncology insights Pub Date : 2022-06-15 DOI: 10.18609/ioi.2022.035
R. McGuigan
{"title":"Putting the patient first","authors":"R. McGuigan","doi":"10.18609/ioi.2022.035","DOIUrl":"https://doi.org/10.18609/ioi.2022.035","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42080387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Redefining success: predicting checkpoint inhibitor toxicity to improve patient outcomes 重新定义成功:预测检查点抑制剂毒性以改善患者预后
Immuno-oncology insights Pub Date : 2022-06-15 DOI: 10.18609/ioi.2022.030
J. Weidhaas
{"title":"Redefining success: predicting checkpoint inhibitor toxicity to improve patient outcomes","authors":"J. Weidhaas","doi":"10.18609/ioi.2022.030","DOIUrl":"https://doi.org/10.18609/ioi.2022.030","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41613668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the challenges of CRS in bispecific monoclonal antibody cancer therapy 解决CRS在双特异性单克隆抗体癌症治疗中的挑战
Immuno-oncology insights Pub Date : 2022-06-15 DOI: 10.18609/ioi.2022.031
A. Vaze, P. Kuebler
{"title":"Addressing the challenges of CRS in bispecific monoclonal antibody cancer therapy","authors":"A. Vaze, P. Kuebler","doi":"10.18609/ioi.2022.031","DOIUrl":"https://doi.org/10.18609/ioi.2022.031","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41859349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-centered care in immuno-oncology: current progress & opportunities when considering safety & tolerability 免疫肿瘤学中以患者为中心的护理：在考虑安全性和耐受性时的当前进展和机遇
Immuno-oncology insights Pub Date : 2022-06-15 DOI: 10.18609/ioi.2022.029
C. Adessi, D. Rüttinger
{"title":"Patient-centered care in immuno-oncology: current progress & opportunities when considering safety & tolerability","authors":"C. Adessi, D. Rüttinger","doi":"10.18609/ioi.2022.029","DOIUrl":"https://doi.org/10.18609/ioi.2022.029","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45314069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on antibody–drug conjugates: where are we now, & where are we going? 抗体-药物偶联物最新进展:我们现在在哪里，我们将向哪里发展?
Immuno-oncology insights Pub Date : 2022-06-07 DOI: 10.18609/ioi.2022.022
F. Arnaldez
{"title":"Update on antibody–drug conjugates: where are we now, & where are we going?","authors":"F. Arnaldez","doi":"10.18609/ioi.2022.022","DOIUrl":"https://doi.org/10.18609/ioi.2022.022","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45808927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Site specific responses to immune checkpoint inhibitors 免疫检查点抑制剂的位点特异性反应
Immuno-oncology insights Pub Date : 2022-06-07 DOI: 10.18609/ioi.2022.032
Clinton Wu, A. Daud
{"title":"Site specific responses to immune checkpoint inhibitors","authors":"Clinton Wu, A. Daud","doi":"10.18609/ioi.2022.032","DOIUrl":"https://doi.org/10.18609/ioi.2022.032","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47690774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolution of combination immunotherapy: current successes & future goals 联合免疫疗法的发展：当前的成功与未来的目标
Immuno-oncology insights Pub Date : 2022-06-07 DOI: 10.18609/ioi.2022.025
Roy Baynes
{"title":"The evolution of combination immunotherapy: current successes & future goals","authors":"Roy Baynes","doi":"10.18609/ioi.2022.025","DOIUrl":"https://doi.org/10.18609/ioi.2022.025","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42473598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spotlight on combination therapy development: strategic directions towards improving current I-O response rates 聚焦联合治疗发展：提高当前I-O反应率的战略方向
Immuno-oncology insights Pub Date : 2022-06-07 DOI: 10.18609/ioi.2022.026
A. Daud, A. Haugh, S. Jacob
{"title":"Spotlight on combination therapy development: strategic directions towards improving current I-O response rates","authors":"A. Daud, A. Haugh, S. Jacob","doi":"10.18609/ioi.2022.026","DOIUrl":"https://doi.org/10.18609/ioi.2022.026","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49382855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kick-starting tumor specific T cell priming & targeting the tumor microenvironment using CD40 targeting bispecific antibodies 启动肿瘤特异性T细胞启动和利用CD40靶向双特异性抗体靶向肿瘤微环境
Immuno-oncology insights Pub Date : 2022-04-06 DOI: 10.18609/ioi.2022.019
Karin Hägerbrand, P. Ellmark
{"title":"Kick-starting tumor specific T cell priming & targeting the tumor microenvironment using CD40 targeting bispecific antibodies","authors":"Karin Hägerbrand, P. Ellmark","doi":"10.18609/ioi.2022.019","DOIUrl":"https://doi.org/10.18609/ioi.2022.019","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47076160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy? 量化肿瘤微环境：推进癌症免疫疗法的下一步是什么？
Immuno-oncology insights Pub Date : 2022-04-06 DOI: 10.18609/ioi.2022.012
Ning Wang
{"title":"Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?","authors":"Ning Wang","doi":"10.18609/ioi.2022.012","DOIUrl":"https://doi.org/10.18609/ioi.2022.012","url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47468085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信